The Weight-Loss Jab Epidemic: How Pregnancy Can Turn Women Against Breastfeeding and Themselves
For many women, pregnancy is a time of profound body transformation - not just for their bodies, but also for their minds. The sudden shift in hormonal balance can lead to feelings of overwhelm, anxiety, and self-doubt. For some, this can trigger a familiar but damaging pattern: the pressure to lose weight.
Lydia, a 33-year-old mother from Wales, first started thinking about weight-loss drugs during pregnancy. "Everyone was talking about them and the advertisements were everywhere," she recalls, as her baby son naps upstairs. Her pregnancy brought a level of body acceptance she had never known before, but as her due date approached, a familiar feeling of dread emerged.
In Lydia's antenatal class WhatsApp group, conversations turned to feeding, dieting, and weight loss - topics that were once ignored in favor of more positive discussions. Out of six mums, three decided not to breastfeed or gave up early to go on weight-loss jabs, both of which are advised against during breastfeeding due to their impact on milk quality and supply.
The pressure to lose weight can be overwhelming, especially for new mothers. Melanie, a 31-year-old mum of two, has been injecting GLP-1 agonists since January and has lost five stone. While she feels more comfortable going against NHS guidance, she acknowledges the risks involved. "I did a lot of research, read science papers as much as I could understand them and spoke to my husband about it," she says.
The private provider she bought her Mounjaro from asked if she was breastfeeding, which she ticked off without verification. Melanie had also read experiences of other women on Reddit, but acknowledges that large-scale studies are not available for the safety of these drugs while breastfeeding.
Dr. Jan Toledano, a leading women's hormone specialist and founder of the London Hormone Clinic, warns about the potential health risks of taking weight-loss drugs during the postnatal period. "If there's rapid weight loss, this impacts lots of different things: milk production may cease, yes, but also energy levels may decrease," she notes.
Toledano is concerned that the mass marketing of these drugs directly to consumers is interfering with proper medical care for new mothers. "If a woman is reaching for the GLP-1 agonists because they're advertised all the time and everyone's on them, she's not going to see a doctor who understands metabolic changes after pregnancy," which can put them at risk.
The Breastfeeding Network's Drugs in Breastmilk service reports an increase of 145% in enquiries from breastfeeding mothers about weight loss. "GLP-1 medications such as Mounjaro are not recommended for use while breastfeeding" says Amanda Da Costa, clinical supervisor.
Melanie has now stopped taking Mounjaro, citing the ease with which postnatal women can get drawn into the marketing of these drugs or omit information to obtain them. "You are quite vulnerable; your hormones are all over the place, lack of sleep and all of that," she says.
Lydia has decided not to take the drugs, opting instead for body acceptance during this critical period. "Ultimately, my child comes before this incessant need to be thin," she says, although she acknowledges that if advised it is safe to do so, she may consider taking them in the future. She resents that, like many women, she must choose between bouncing back and breastfeeding - two societal pressures that can feel insurmountable.
The weight-loss jab epidemic has left a trail of vulnerable mothers in its wake, forced to navigate a complex web of conflicting advice and commercial pressure. As new parents, we must prioritize our health and the well-being of our children above all else.
For many women, pregnancy is a time of profound body transformation - not just for their bodies, but also for their minds. The sudden shift in hormonal balance can lead to feelings of overwhelm, anxiety, and self-doubt. For some, this can trigger a familiar but damaging pattern: the pressure to lose weight.
Lydia, a 33-year-old mother from Wales, first started thinking about weight-loss drugs during pregnancy. "Everyone was talking about them and the advertisements were everywhere," she recalls, as her baby son naps upstairs. Her pregnancy brought a level of body acceptance she had never known before, but as her due date approached, a familiar feeling of dread emerged.
In Lydia's antenatal class WhatsApp group, conversations turned to feeding, dieting, and weight loss - topics that were once ignored in favor of more positive discussions. Out of six mums, three decided not to breastfeed or gave up early to go on weight-loss jabs, both of which are advised against during breastfeeding due to their impact on milk quality and supply.
The pressure to lose weight can be overwhelming, especially for new mothers. Melanie, a 31-year-old mum of two, has been injecting GLP-1 agonists since January and has lost five stone. While she feels more comfortable going against NHS guidance, she acknowledges the risks involved. "I did a lot of research, read science papers as much as I could understand them and spoke to my husband about it," she says.
The private provider she bought her Mounjaro from asked if she was breastfeeding, which she ticked off without verification. Melanie had also read experiences of other women on Reddit, but acknowledges that large-scale studies are not available for the safety of these drugs while breastfeeding.
Dr. Jan Toledano, a leading women's hormone specialist and founder of the London Hormone Clinic, warns about the potential health risks of taking weight-loss drugs during the postnatal period. "If there's rapid weight loss, this impacts lots of different things: milk production may cease, yes, but also energy levels may decrease," she notes.
Toledano is concerned that the mass marketing of these drugs directly to consumers is interfering with proper medical care for new mothers. "If a woman is reaching for the GLP-1 agonists because they're advertised all the time and everyone's on them, she's not going to see a doctor who understands metabolic changes after pregnancy," which can put them at risk.
The Breastfeeding Network's Drugs in Breastmilk service reports an increase of 145% in enquiries from breastfeeding mothers about weight loss. "GLP-1 medications such as Mounjaro are not recommended for use while breastfeeding" says Amanda Da Costa, clinical supervisor.
Melanie has now stopped taking Mounjaro, citing the ease with which postnatal women can get drawn into the marketing of these drugs or omit information to obtain them. "You are quite vulnerable; your hormones are all over the place, lack of sleep and all of that," she says.
Lydia has decided not to take the drugs, opting instead for body acceptance during this critical period. "Ultimately, my child comes before this incessant need to be thin," she says, although she acknowledges that if advised it is safe to do so, she may consider taking them in the future. She resents that, like many women, she must choose between bouncing back and breastfeeding - two societal pressures that can feel insurmountable.
The weight-loss jab epidemic has left a trail of vulnerable mothers in its wake, forced to navigate a complex web of conflicting advice and commercial pressure. As new parents, we must prioritize our health and the well-being of our children above all else.